Effects of PPAR&ggr; Agonists against Vascular and Renal Dysfunction

E-ISSN： 1874-4702|5|2|248-254

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.5, Iss.2, 2012-06, pp. : 248-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPAR-&ggr; Agonists as Regulators of Microglial Activation and Brain Inflammation

Current Pharmaceutical Design, Vol. 12, Iss. 1, 2006-01 ,pp. : 93-109

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotective effects of PPAR agonists against oxidative insults in HT-22 cells

By Aoun P. Watson D.G. Simpkins J.W.

European Journal of Pharmacology, Vol. 472, Iss. 1, 2003-07 ,pp. : 65-71

Elsevier

Access to resources Recommend Favorite

Effects of PPAR&ggr; Ligands on Vascular Tone

Current Molecular Pharmacology, Vol. 5, Iss. 2, 2012-01 ,pp. : 282-291

Bentham Science Publishers

Access to resources Recommend Favorite

Measuring biomarkers to assess the therapeutic effects of PPAR agonists?

By Chinetti-Gbaguidi Giulia Staels Bart

Pharmacogenomics, Vol. 8, Iss. 11, 2007-11 ,pp. : 1567-1580

Future Medicine

Access to resources Recommend Favorite

Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer

Current Medicinal Chemistry, Vol. 23, Iss. 7, 2016-02 ,pp. : 636-649

Bentham Science Publishers

Access to resources Recommend Favorite